csirt@kutim:~/threat-intel/cve/CVE-2024-22412

Katalog CVE

CVSS 4.9 · Medium EPSS 0,59%

Kerentanan Incorrect Authorization pada clickhouse, clickhouse cloud. Skor CVSS 3.1 4.9 (Medium) menurut NVD.

Deskripsi (NVD)

ClickHouse is an open-source column-oriented database management system. A bug exists in the cloud ClickHouse offering prior to version 24.0.2.54535 and in github.com/clickhouse/clickhouse version 23.1. Query caching bypasses the role based access controls and the policies being enforced on roles. In affected versions, the query cache only respects separate users, however this is not documented and not expected behavior. People relying on ClickHouse roles can have their access control lists bypassed if they are using query caching. Attackers who have control of a role could guess queries and see data they shouldn't have access to. Version 24.1 of ClickHouse and version 24.0.2.54535 of ClickHouse Cloud contain a patch for this issue. Based on the documentation, role based access control should be enforced regardless if query caching is enabled or not.

Rincian

Terbit di NVD
18 Maret 2024
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
4.9 (Medium), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:N/A:N · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-863: Incorrect Authorization
EPSS (30 hari)
0,59% peluang dieksploitasi; lebih tinggi dari 46,8% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
clickhouse clickhouse Versi 23.3.0.0 hingga sebelum 23.3.22.3
clickhouse clickhouse Versi 23.8.0.0 hingga sebelum 23.8.12.13
clickhouse clickhouse Versi 23.12.0.0 hingga sebelum 23.12.6.19
clickhouse clickhouse Versi 24.0.0.0 hingga sebelum 24.1.1.2048
clickhouse clickhouse cloud Semua versi sebelum 24.0.2.54535

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.